Loading ...

Lyudmila Lyakh

NIAID

Assessment Group

lyudmill@mail.nih.gov

Work:

240-627-3530

Mobile:

301-480-1537

Address:

NIAID

Committees:

,

Studies:

ITN028AI

-

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

ITN032AD

-

Promoting Tolerance to Peanut in High-Risk Children

ITN034AI

-

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

ITN041AI

-

A Research Trial of Aralast in New Onset Diabetes

ITN045AI

-

Inducing Remission in Type 1 Diabetes With Alefacept

ITN049AD

-

Persistence of Oral Tolerance to Peanut

ITN052AD

-

Peanut Protein Quantification Study for LEAP

ITN053AD

-

Peanut protein quantification study for LEAP-ON

ITN055AI

-

Rituximab and Belimumab for Lupus Nephritis

ITN058AI

-

Tocilizumab (TCZ) in New-onset Type 1 Diabetes

ITN059AI

-

Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris

ITN062ST

-

Tolerance by engaging antigen during cellular homeostasis

ITN064AI

-

Imaging of Type 1 Diabetes Progression

ITN065AI

-

TCZ in Pediatric New-onset T1D

ITN066AI

-

Type 1 Diabetes Extension Study

ITN070AD

-

ITN078AI

-

Immunotherapy to Preserve Residual Insulin in New-onset Type One Diabetes

ITN095AI

-

Siplizumab in T1DM

ITN100ST

-

Siplizumab for Liver Transplant Tolerance

Bio:

Admin Links

Shortcuts

ITN Documents

Links